Cancer is now a leading cause of death in developed countries: more than 150,000 per year in France and more than 550,000 in the United States. It is a complex disease caused by a genetic instability and accumulation of multiple molecular changes. The treatment most commonly used are limited to chemotherapy, radiation or cancer surgery.
Nanotechnology have strong potential for significant advances in cancer treatment. In the United States, the National Cancer Institute (NCI) set up in autumn 2004 the Alliance for Nanotechnology in Cancer. A plan for 5 years with $ 144.3 million was launched in 2005,
read more from "Fighting Cancer using the Nanotechnology: the American effort"
